Life-saving cancer drug takes a major step closer to patient care
A new drug candidate for hard-to-treat cancers, discovered at the University of Edinburgh and licensed by biopharmaceutical company Nuvectis Pharma, Inc. (“Nuvectis” or “Company”), can now begin clinical trials as announced by Nuvectis.
The compound,...
Biochemical synthesis breakthrough could unlock new medicines
A mystery about lab synthesis of a natural chemical compound may have been solved – a breakthrough which could unlock new developments in medicine.
Scientists in Scotland and Germany made the discovery, published in the...
Hijacking our cell enzymes to eliminate disease-causing proteins
By studying how enzymes move from one membrane compartment to another inside a cell, scientists at the University of Illinois Chicago have figured out a way to better target cellular proteins, which play a...
New drugs partnership tackles lung disease
Aston University scientists are working with start-up company, Isterian Biotech, part of Cambrian BioPharma, to develop novel drugs to treat fibrotic diseases such as lung disease.
The focus of preclinical-stage biotechnology company Isterian Biotech is...